Chemical Structure : LOXO-101 sulfate
CAS No.: 1223405-08-0
Catalog No.: PC-43266Not For Human Use, Lab Use Only.
LOXO-101 (ARRY-470, Larotrectinib) is potent, selective pan-TRK inhibitor with cellular IC50 of 2-20 nM against TRKA, TRKB, and TRKC kinases.
Packing | Price | Stock | Quantity |
---|---|---|---|
5 mg | $75 | In stock | |
25 mg | $175 | In stock | |
100 mg | $465 | In stock | |
500 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
LOXO-101 (ARRY-470, Larotrectinib) is potent, selective pan-TRK inhibitor with cellular IC50 of 2-20 nM against TRKA, TRKB, and TRKC kinases; demonstrates excellent selectivity against a panel of 226 non-TRK kinases with one exception (TNK2 IC50=576 nM); inhibits fusion oncoprotein and cellular proliferation in TRK-fusion-bearing human-derived cancer cell lines; markedly attenuates bone cancer pain and significantly blocks the ectopic sprouting of sensory nerve fibers and the formation of neuroma-like structures in the tumor bearing bone; inhibits tumor growth in vivo in TRK fusion-positive cancer models.
Blood Cancer
Phase 2 Clinical
M.Wt | 526.5137 | |
Formula | C21H24F2N6O6S | |
Appearance | Solid | |
Storage |
|
|
Solubility |
DMSO |
|
Chemical Name/SMILES |
1-Pyrrolidinecarboxamide, N-[5-[(2R)-2-(2,5-difluorophenyl)-1-pyrrolidinyl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxy-, (3S)-, sulfate (1:1) |
1. Doebele RC, et al. Cancer Discov. 2015 Oct;5(10):1049-57.
2. Ghilardi JR, et al. Mol Pain. 2010 Dec 7;6:87.
3. Vaishnavi A, et al. Nat Med. 2013 Nov;19(11):1469-1472.
4. Drilon A, et al. N Engl J Med. 2018 Feb 22;378(8):731-739.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright